Evaxion Biotech's total assets for Q1 2024 were $22.65M, an increase of 75.77% from the previous quarter. EVAX total liabilities were $20.05M for the fiscal quarter, a 13.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.